Shifting paradigms: the seeds of oncogene addiction

Nat Med. 2009 Oct;15(10):1158-61. doi: 10.1038/nm1009-1158.
No abstract available

Publication types

  • Biography
  • Historical Article
  • Portrait

MeSH terms

  • Awards and Prizes*
  • Benzamides
  • Clinical Trials as Topic
  • DNA, Complementary
  • Drug Resistance / genetics*
  • History, 20th Century
  • History, 21st Century
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
  • Mutation*
  • Neoplasms / genetics*
  • Neoplasms / therapy
  • Oncogenes / drug effects*
  • Oncogenes / genetics*
  • Piperazines / chemistry
  • Piperazines / therapeutic use
  • Protein Kinase Inhibitors / chemistry
  • Protein Kinase Inhibitors / therapeutic use
  • Protein Structure, Tertiary / genetics
  • Pyrimidines / chemistry
  • Pyrimidines / therapeutic use
  • Sequence Analysis, DNA
  • United States

Substances

  • Benzamides
  • DNA, Complementary
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Imatinib Mesylate

Personal name as subject

  • Charles L Sawyers